Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus

Abstract

ObjectivesCardiovascular autonomic neuropathy (CAN) may affect the clinical course of SLE leading to reduced quality of life. CAN is assessed by heart rate variability (HRV) measures and cardiovascular autonomic reflex tests (CARTs). In patients with SLE, we aimed to determine the characteristics of CAN and if CAN associates with health-related quality of life (HRQoL).MethodsPatients with SLE and healthy controls (HCs) were CAN tested with 5 min HRV and three CARTs to determine parameters reflecting parasympathetic and mixed sympathetic–parasympathetic function. Subjects were classified as having no, early or definitive CAN by having none, one or more than one abnormal CART, respectively. HRQoL as determined by the Short Form 12 (SF-12) was assessed in SLE.ResultsOf 111 patients with SLE, 92 answered the SF-12 and 54 were matched with 54 HCs for characterisation of CAN. Definitive CAN was present in 24.1% (95% CI 15% to 37%) patients with SLE and 1.9% (95% CI 0.3% to 9.8%) HCs (OR 16.8, 95% CI 2.1 to 133.8, p=0.008). The corresponding prevalences of any CAN were 53.7% (95% CI 41% to 66%) and 22.6% (95% CI 13% to 35%). SLE patients with definitive CAN showed signs of mixed sympathetic–parasympathetic dysfunction, whereas patients without CAN primarily presented with impaired parasympathetic activity. Signs of parasympathetic as well as sympathetic–parasympathetic dysfunction were associated with low physical SF-12 component score (all: β>0.211, p<0.05). The mental SF-12 component score was not associated with any CAN indices.ConclusionsCAN was a frequent finding in SLE and associated to self-report on impaired physical HRQoL. Even patients without CAN showed signs of impaired parasympathetic function compared with controls.

Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus

“…A total of 79 patients with an established diagnosis of SLE according to the 1997 American College of Rheumatology Revised criteria were included from October 2018 through March 2019 from our tertiary referral center for systemic autoimmune diseases at Copenhagen University Hospital, Rigshospitalet, Denmark. Patients were recruited as previously described [ 33 ]. Patients were 18 years of age or older.…”

Should Renal Inflammation Be Targeted While Treating Hypertension?

“…Basal activity of the hypothalamic-pituitary-adrenal (HPA) axis contributes to the suppression of peripheral inflammation by the release of corticosterone. Additionally, decreased parasympathetic (vagal) tone, as indicated by decreased heart rate variability, has been consistently identified in clinical studies involving SLE patients since 1997 ( Laversuch et al, 1997 ; Maule et al, 1997 ; Thanou et al, 2016 ; Matusik et al, 2018 ; Zinglersen et al, 2021 ). An impaired HPA axis is present in SLE and may explain why renal inflammation is not resolved in SLE ( Rovenský et al, 1998 ; Pham and Mathis, 2018 ).…”

Vision-Related Quality of Life in Patients with Systemic Lupus Erythematosus

“…SLE may be also associated with Sjögren syndrome or antiphospholipid syndrome, among others. Consequently, patients with SLE may refer to a reduced health-related quality of life (HRQoL) [ 2 ]. Treatment with hydroxychloroquine (HCQ) increases life expectancy in these patients [ 3 , 4 ], as well as increasing their HRQoL [ 5 ].…”